AstraZeneca Pharma surges on receiving marketing permission for Olaparib

17 Aug 2018 Evaluate

Astrazeneca Pharma India is currently trading at Rs. 1750.00, up by 39.70 points or 2.32% from its previous closing of Rs. 1710.30 on the BSE.

The scrip opened at Rs. 1756.00 and has touched a high and low of Rs. 1776.85 and Rs. 1745.80 respectively. So far 1491 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1823.40 on 03-Aug-2018 and a 52 week low of Rs. 882.55 on 22-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1,780.00 and Rs. 1655.10 respectively. The current market cap of the company is Rs. 4275.75 crore.

The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 6.25% and 18.75% respectively.

AstraZeneca Pharma India has received Import & Market permission for olaparib (Lynparza) 100 mg and 150 mg tablets in India by the Drug Controller General of India (DCGI). The receipt of this permission paves way for the launch of olaparib (Lynparza) in India, subject to the receipt of further related statutory approvals and licenses.

For ovarian cancer, olaparib is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.

For breast cancer, olaparib is indicated for patients with deleterious or suspected deleterious gBRCAm, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

AstraZeneca Pharma India is a global biopharmaceutical company. The company is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease. The company operates through two segments Healthcare and Clinical Trial.


Astrazeneca Pharma I Share Price

8908.70 -254.05 (-2.77%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×